13 July 2023 - NICE is unable to make a recommendation on the use of semaglutide (Wegovy) on the NHS for ...
12 July 2023 - NICE has published final evidence-based recommendations on the use of lorlatinib (Lorviqua) for the treatment of ...
5 July 2023 - NICE has published final evidence-based recommendations on the use of rimegepant sulphate (Vydura) for the prevention ...
5 July 2023 - NICE has published final evidence-based recommendations on the use of olaparib (Lynparza) for the maintenance treatment ...
29 June 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
28 June 2023 - NICE has published final evidence-based recommendations on the use of deucravacitinib for the treatment of adults ...
27 June 2023 - A public consultation on updates to NICE’s health technology evaluations manual is now open. ...
27 June 2023 - More evidence is needed on the clinical and cost effectiveness of a new treatment option for patients ...
27 June 2023 - The Department of Health and Social Care has asked the NICE to review its guidance on ...
26 June 2023 - Dr Sam Roberts has been outlining the changes underway at NICE to meet the challenges of a ...
26 June 2023 - The King’s Fund today published their independent report commissioned by the ABPI comparing the NHS to other ...
21 June 2023 - NICE has published final evidence-based recommendations on the use of upadacitinib monohydrate (Rinvoq) for the treatment ...
21 June 2023 - NICE has published final evidence-based recommendations on the use of pembrolizumab (Keytruda) in combination with lenvatinib ...
21 June 2023 - NICE has published final evidence-based recommendations on the use of darolutamide (Nubeqa) in combination with androgen ...
21 June 2023 - NICE has published final evidence-based recommendations on the use of dapagliflozin propanediol monohydrate for the treatment ...